Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 188 results found. Search for [ pfizer and moderna news ]

Results 1 to 21 of 188
Reuters
June 10, 2021
India has not granted indemnity to any COVID-19 vaccine maker, but the sources said the government was having a change of heart


Reuters
June 6, 2021
A meeting of trade ministers from the 21-economy group also produced pledges to support World Trade Organization negotiations for an intellectual property waiver on COVID-19 vaccines


Associated Press
June 3, 2021
The US has said it plans to share 80 million vaccine doses globally by the end of June. The administration says 25% will be kept in reserve for emergencies and for the U.S. to share directly with allies and partners


BusinessToday.In
New Delhi, June 3, 2021
A string of 43 hikes this year as compared to just four cuts has seen prices of petrol and diesel break all records in India this year; Corporate tax collection fell below personal income tax collection for the first time in 12 years due to lower tax rates and the COVID-19 impact on businesses; In an attempt to help families of employees that have lost members to COVID-19, Mukesh Ambani-helmed Reliance Industries has announced that it will continue to pay the last-drawn salary of the deceased employee to his or her nominee for the next five years. Watch this and more on News Blast.Also Read: Pfizer, Moderna, Serum & the indemnity issue; what is it and what it means for India?


BusinessToday.In
June 3, 2021
This development comes a day after reports suggested that the Centre is leaning towards granting indemnity to foreign vaccine makers including Pfizer and Moderna


BusinessToday.In
June 2, 2021
In the first phase of Vande Bharat Mission, 490 international flights had landed at the Vijaywada airport, bringing over 55,000 passengers from different countries.


BusinessToday.In
June 2, 2021
Like other nations, the Indian government is also expected to grant indemnity to foreign drugmakers like Pfizer and Moderna if they seek drug regulator's nod for the Emergency Use Authorisation (EUA)


Reuters
June 2, 2021
Biden on Monday said his administration will send at least 20 million doses of the Pfizer-BioNTech, Moderna and Johnson & Johnson vaccines, on top of 60 million AstraZeneca doses he had already planned to give to other countries


PB Jayakumar
June 2, 2021
DCGI said the requirement of conducting post approval bridging clinical trials and requirement of testing of every batch of vaccine by the CDL can be exempted, if the vaccine lot/batch is certified and released by National Control Laboratory of country of origin


Reuters
June 1, 2021
Biological E. will run a clinical trial of Providence's vaccine in India and seek emergency use approval for it, the company said in a statement


Reuters
June 1, 2021
The development comes weeks after rival Pfizer Inc and its German partner BioNTech SE sought full approval for their COVID-19 vaccine in the United States


PTI
June 1, 2021
Researchers at the Rockefeller University in the US analysed antibodies present in the blood of Covid patients, tracking the evolution of these molecules


BusinessToday.In
May 29, 2021
The Delhi government has floated the global tender to scale up the COVID-19 vaccination drive in the national capital


Reuters
May 29, 2021
The decision comes after European Medicines Agency (EMA) backed the use of the vaccine in 12- to 15-year olds earlier in the day


BusinessToday.In
May 28, 2021
BajajHealthcare share rose to a record high of Rs 700 rising 10% against previousclose of Rs 636.05 on BSE


BusinessToday.In
New Delhi, May 26, 2021
Cyclone Yaas intensified into a very severe cyclonic storm on Tuesday evening, India Meteorological Department Director General M Mohapatra said; Delhi recorded 156 Covid fatalities on Tuesday, the lowest since April 16, while 1,568 new cases were reported as the positive rate dipped to nearly two-month low of 2.14 per cent, according to the daily health bulletin; The economic costs of the second wave of COVID-19 pandemic in India and lockdowns to curb spread of infection are rising rapidly, and may cost India $74 billion (about Rs 5.4 lakh crore) during April-June quarter, according to Barclays. Watch this and more news on News Blast.Also Read: India proud of scientists who worked on COVID-19 vaccines: PM Modi


PTI
May 25, 2021
In a high level meeting it was discussed that Moderna doesn't have surplus vaccines to share in 2021 and that it plans to launch its single-dose vaccine for the Indian market only in 2022


PTI
May 21, 2021
The Centre will also take up with Moderna, Johnson and Johnson and other vaccine makers the issue of granting voluntary licence to third-party manufacturers in India on transfer of technology basis


Reuters
May 21, 2021
Moderna is the fourth COVID-19 vaccine to be approved in South Korea, following doses developed by AstraZeneca Plc , Pfizer Inc and Johnson & Johnson, said Kim


PTI
May 16, 2021
Moderna has been widely used in countries such as Canada, United States and the United Kingdom under emergency use authorisations granted by these countries and the World Health Organisation.


PAGES 1 OF 10  12345